Orforglipron is an investigational, once-daily oral GLP-1 medication being studied for the treatment of type 2 diabetes and obesity. It belongs to a class of medicines called GLP-1 receptor agonists and is designed to help lower blood sugar and support weight loss. It comes in a pill form. In clinical trials, it was taken once a day at any time, without food or water restrictions.